Organofab Technologies, Inc.

From regenerative medicine to organ replacement and cancer immunotherapy, incredible developments in medicine are poised to revolutionize patient care in the very near term - an improvement in quality of life that also represents a huge economic opportunity. Organofab™ technology will facilitate the integration of many new techniques and tools to not only enable but also evolve the tissue engineering field. We envision combining 3D bioprinting and advanced nanotechnology techniques with state of the art equipment in our novel patented infrastructure. At the point of care, this system will produce differentiated, patient-specific cell types in naturally consistent structures, modeled after the patient’s existing anatomy.